Northwestern University
Business

FDA Approval and Preemption of Products Liability Claims

0 Reviews
Views

Elizabeth J. Cabraser of Lief, Cabraser, Heimann and Bernstein, LLP, San Francisco, addresses the panel on "FDA Approval and Preemption of Products Liability Claims," at the Judicial Symposium on The Pharmaceutical Industry: Economics, Regulation, and Legal Issues, hosted by the Northwestern Law Judicial Education Program in May 2009.

Related Presentations

Featured Presentations

API Importation Panel
Org
Video
00:27:02

Pharma ChemOutsourcing

Discussion on the reform in FDA inspection of offshore pharmaceutical/API manufacturing.
Agilent Mass Q-TOF LC/MS
Org
Video
00:04:08

Sensitive, Accurate-Mass MS and MS/MS Analyses

Typical mass accuracy – sub-1-ppm MS and 2-ppm MS/MS rivals or exceeds that of much more expensive FTMS and orbital…

Excipients by ISP

Featuring binders, disintergrants, coatings, and solubilizers.
www.isppharmaceuticals.com

Active Ingredients

Buy active ingredients from the market leader EMD Chemicals now!
www.EMDchemicals.com/Ingredients

Pharma Outsourcing Trends

Find Market Research & Analysis on Pharmaceutical Outsourcing Industry
www.KaloramaInformation.com/Pharma-Out

Alchem Laboratories

cGMP Manufacturing, Drug Development and Specialty Chemicals
www.alchem.com

Mass Spec Analytical Lab

Molecular Characterization Services EI-MS, CI-MS, GC-MS, LC-MS
www.ImpactAnalytical.com